Below, please find a statement on the Janssen U.S. Transparency Report from Joaquin Duato, Johnson & Johnson Executive Vice President and Worldwide Chairman, Pharmaceuticals. You can view the full report on Janssen.com.
“We are pleased to release the inaugural Janssen U.S. Transparency Report, in which we are disclosing more information about our business practices, including those related to pricing. This report builds on our history of responsible pricing practices and our ongoing efforts to provide more transparency into how we operate. These disclosures are steps that we can take as one company as we continue to work with others in the health care system to address stakeholder concerns about U.S. health care costs.” - Joaquin Duato, Executive Vice President and Worldwide Chairman, Pharmaceuticals
